Prof. Andrew Gennery Bio : Prof. Andrew Gennery

Prof. Andrew Gennery

· Special Interests

Paediatric Immunology and Haematopoietic Stem Cell Transplantation.

Andrew Gennery spent a year of post-doctoral studies working with Anne Durandy and Alain Fischer in the Necker Hospital in Paris and was involved in the discovery of Cytidine Deaminase one of the first genes to be discovered involved in class switch recombination and somatic hypermutation.

His research interests include immunoreconstitution following haematopoietic stem cell transplant for primary immunodeficiency, long-term outcomes of transplantation for primary immunodeficiency DNA repair disorders and their appropriate treatment. He has adapted new methods of T-cell depletion for patients with primary immunodeficiency, and established extracorporeal photopheresis for the treatment of children with graft versus host disease.

He is a member of ESID and EBMT and currently chairs the ESID/EBMT Inborn Errors Working Party group. He has written international guidelines for the treatment of patients with DNA repair disorders and CD40 ligand deficiency. He is currently part of the working group writing guidelines for the use of extracorporeal photopheresis for the treatment of acute graft versus host disease.

He is currently Programme Director for the Academic Foundation Programme in the Northern Deanery. He is the Human Tissue Authority Designated Individual overseeing tissue for therapeutic use within Newcastle

 


View: 306 Time(s)   |   Print: 47 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2015 All Rights Reserved | ICIAAI 2017, The Third International Congress of Immunology, Asthma and Allergy

Designed & Developed by : Yektaweb